Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company

Preclinical Oncology Services Ltd , a leading preclinical R&D service with a specific focus on oncology, announces its official launch following its spin-out from the University of Nottingham.

Preclinical Oncology Services Ltd (PRECOS), a leading preclinical R&D service with a specific focus on oncology, announces its official launch following its spin-out from the University of Nottingham (UK). The newly formed company combines the innovation of one of the country's leading universities with the scientific background and expertise of multidisciplinary scientists. This places the company in an optimal position to deliver specialist services, backed by significant industry expertise and cutting-edge technology, to help both pharmaceutical and biotechnology companies develop new anti-cancer drugs.

PRECOS was officially launched as a specialist business unit of the University of Nottingham in 2004, having evolved from the research expertise of the Division of Preclinical Oncology (formerly Academic Unit of Cancer Studies). This unit has had successful collaborations with pharmaceutical and biotech companies in Europe, US and Japan for more than a decade. The ne